Offering Expertise in MS Diagnosis and Treatment at Any Stage of the Disease
Multiple sclerosis (MS) is a complex autoimmune disease that attacks the central nervous system, impairing muscle function, bowel and bladder function, vision, hearing, speech and more. MS is most commonly diagnosed in women between 20 and 40 years of age, although it can affect men and women of various ages.
Because of its complexity, MS can be difficult to diagnose. Yet an accurate diagnosis is key to developing an effective treatment plan.
SLUCare neuroimmunologist Dr. Lokesh Rukmangadachar is fellowship trained in the identification and treatment of MS. Through careful evaluation, Dr. Rukmangadachar distinguishes between symptoms of multiple sclerosis and diseases with similar profiles, such as neuromyelitic optica (Devic’s disease) or other systemic autoimmune conditions affecting the brain, to deliver a more accurate diagnosis.
Developing a personalized MS treatment plan
Today’s patients have a greater range of MS treatment options than any previous generation. There are more FDA-approved medications than ever before, each with its own unique profile to modify and slow the course of MS.
Dr. Rukmangadachar understands the differences in today’s MS medications and can help you determine which approaches may be most beneficial for you. He listens to your concerns and goals for treatment, and uses your input to develop a treatment plan tailored to your needs.
In addition to medication, Dr. Rukmangadachar coordinates all other elements of a comprehensive MS treatment plan, including:
- Consults with specialists in physical therapy, occupational therapy, ophthalmology, psychiatry and neuropsychology, urology and social work
- Disease monitoring through clinical follow-up, neurological testing, lab testing and imaging, including state-of-the-art MRI scans using dedicated MS protocols
- Medication coordination and patient education with experienced MS nurses
- Referrals to infusion centers at SSM Health Saint Louis University Hospital - West Pavilion and at the SLUCare Des Peres Infusion Center
- Access to clinical trials, as applicable
Engaging patients in the decision-making process improves communication, encourages feelings of empowerment and control over the disease, and enhances comfort level with both the treatment plan and outcome. It’s personalized care backed by the resources of an academic medical practice.
For an appointment with Dr. Rukmangadachar, call 314-977-6082.